A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

A multicenter study to compare multiple doses of intravitreal microplasmin in patients undergoing surgical vitrectomy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ThromboGenics
• Treatments: Fibrinolysin; Plasminogen

Criteria

Inclusion Criteria:

• Patients in whom vitrectomy is indicated

Exclusion Criteria:

• Posterior Vitreous Detachment (PVD) present at baseline

• Vitreous hemorrhage

• Certain vitreoretinal conditions including proliferative disease, rhegmatogenous retinal detachment, and proliferative vitreoretinopathy (PVR)

• Have had a vitrectomy in the study eye at any time